Form D · Other Health Care
Candesant Biomedical, Inc.
Nashville, TN · CIK 0001802148
Offering snapshot reported Jun 6, 2023 · SEC filing
- Reported sold
- $35.4M Offering amount: $35.4M
- Investors reported
- 59 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 12, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 6, 2023 | Initial | $35,360,875 | No comparison | 59 | SEC filing |
| Feb 18, 2020 | Initial | $9,133,432 | No comparison | 33 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-483421
Source: Form D, filed Jun 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Samara L. Braunstein | Director |
| Robert L. Grove, Ph.D. | Director |
| Brad Hauser | Director |
| Niquette L. Hunt | Director, Executive |
| Michael Kane | Director |
| Michael A. C. Kane, M.D. | Director |
| Mary Beth Kreissler | Executive |
| Karen Long | Director |
| Eileen L. Mc Guire | Director |
| Amy L. Schulman | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1718 Church Street # 1458
Nashville, TN, 37203
Nashville, TN, 37203